Pfizer to pay Medimpex, LASCO $1b in failed suit
Barbara Gayle, Justice Coordinator
International pharmaceutical company Pfizer, which is facing a $1 billion bill in compensation and legal costs to local distributors Lasco and Medimpex in a dispute over a blood-pressure medication, has lost its appeal to the United Kingdom Privy Council.
In handing down its decision yesterday, the Privy Council upheld a 2012 Court of Appeal ruling, which had upheld a 2009 Supreme Court ruling in favour of Lasco and Medimpex.
At the centre of the dispute is the drug Amlodipine (Norvase) which is used to treat high blood pressure.
Jamaican attorneys-at-law Dr Lloyd Barnett, Vincent Chen and Ian Robins who appeared with English lawyer James Guthrie QC, for Lasco and Medimpex, had urged the Privy Council not to disturb the Court of Appeal ruling.